IV Fluid Delivery System is Estimated to Witness High Growth Owing to Growing Demand for Non-PVC IV Bags
IV Fluid Delivery System is Estimated to Witness High Growth Owing to Growing Demand for Non-PVC IV Bags
The global Non-PVC IV Bags Market is estimated to be valued at US$ 1.3 billion in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

IV fluid delivery systems, also known as intravenous therapy, are medical devices that deliver fluids, nutrients, and medications directly into a patient's circulatory system. Non-PVC IV bags are commonly used in IV fluid delivery systems. These bags are made from materials like polyethylene and copolymers that are free of phthalates and plasticizers. They provide enhanced biocompatibility and reduced risk of particles contaminating infusions as compared to conventional PVC bags. The Non-PVC IV bags are compatible with a wide range of nutrient solutions and drugs administration. These bags offer high clarity for visual inspection of fluids and ensure longer shelf life of medications. The global Non-PVC IV Bags Market is estimated to be valued at US$ 1.3 billion in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The growing demand for Non-PVC IV bags from healthcare facilities across the globe presents a major market opportunity. With rising concerns over health hazards associated with PVC bags, healthcare providers are increasingly adopting Non-PVC alternatives to deliver safer intravenous therapies. The superior biocompatibility features of materials like polyethylene make Non-PVC IV bags ideal for long-term use in chronic conditions requiring prolonged IV treatment regimens. The ability of Non-PVC bags to prevent drug and solution incompatibilities further drive their uptake in healthcare settings. To cater to this growing demand and preference toward Non-PVC IV bags, market players can focus on expanding production capacities and diversifying their product portfolios.

Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate. Starting a new manufacturing facility requires large capital investments and stringent regulatory approvals.
Bargaining power of buyers: The bargaining power of buyers is high. The market has several established players providing similar products giving buyers alternatives to choose from.
Bargaining power of suppliers: The bargaining power of suppliers is moderate. Raw material costs contribute significantly to the production cost. Suppliers have some control over prices.
Threat of new substitutes: The threat of new substitutes is high. Advancements in material science are driving research on novel materials that can replace PVC in IV bags.
Competitive rivalry: Competition in the market is intense with players differentiating through innovation and branding.

SWOT Analysis
Strengths: Non-PVC materials make IV bags bio-compatible and free from harmful leachables. Established manufacturing capabilities and distribution networks give strategic advantages.
Weaknesses: High raw material and production costs can squeeze profit margins. Stringent regulations require extensive clinical validation for new product launches.
Opportunities: Growing prevalence of chronic diseases and increasing healthcare spending in developing nations present an expanding market. Adoption of single-use plastics in hospitals and clinics also supports growth.
Threats: Economic slowdowns and budget constraints in public healthcare systems can delay capital expenditures. Strong reliance on a limited customer base exposes to purchasing power fluctuations.

Key Takeaways
The Global Non-PVC IV Bags Market Demand is expected to witness high growth over the forecast period driven by increasing preference for biocompatible materials in medical devices.

The North American region currently dominates the non-PVC IV bags market owing to stringent regulations banning use of PVC and presence of major industry players. However, Asia Pacific is poised to emerge as the fastest growing regional market led by countries like China, India and South Korea experiencing rapid economic development and expansion in healthcare infrastructure and services.

Key players operating in the non-PVC IV bags market are Baxter International Inc., Sippex IV bag, POLYCINE GmbH, Kraton Corporation, Medline Industries, and Braun Melsungen AG.

 

For more details on the report, Read- https://www.pressreleasebulletin.com/non-pvc-iv-bags-market-growth-market-size-share-analysis/

disclaimer

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations